Introduction
P. Garrido Lopez (Madrid, Spain)
The role of immunotherapy in non-metastasic NSCLC
J. F. Vansteenkiste (Leuven, Belgium)
Upfront immune strategies in advanced NSCLC
N. Rizvi (New York, NY, United States of America)
Present and future of immunotherapy in small cell lung cancer
J. Brahmer (Baltimore, United States of America)
Is immunotherapy an option in mesothelioma?
J. G. Aerts (Rotterdam, Netherlands)
Conclusions and clinical perspectives
J. F. Vansteenkiste (Leuven, Belgium)


























Todos os direitos reservados